-
EP2251330
European procedure
Extract from the Register of European Patents
EP About this file: EP2251330
| EP2251330 - 4-Hydroxybenzomorphans [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 15.03.2013 Database last updated on 02.11.2024 | Most recent event Tooltip | 15.03.2013 | No opposition filed within time limit | published on 17.04.2013 [2013/16] | Applicant(s) | For all designated states RENSSELAER POLYTECHNIC INSTITUTE Office of Technology Commercialization, 110 8th Street Troy, NY 12180 / US | [2010/46] | Inventor(s) | 01 /
Wentland, Mark P. 9 Dennin Drive Menands, New York 12204 / US | [2010/46] | Representative(s) | Graf von Stosch, Andreas, et al Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstraße 22 80538 München / DE | [N/P] |
| Former [2010/46] | Graf von Stosch, Andreas, et al Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22 80538 München / DE | Application number, filing date | 10008474.8 | 03.11.2005 | [2010/46] | Priority number, date | US20040625348P | 05.11.2004 Original published format: US 625348 P | [2010/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2251330 | Date: | 17.11.2010 | Language: | EN | [2010/46] | Type: | B1 Patent specification | No.: | EP2251330 | Date: | 09.05.2012 | Language: | EN | [2012/19] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 15.10.2010 | Classification | IPC: | C07D221/26, A61K31/485, C07D221/28 | [2010/46] | CPC: |
C07D221/28 (EP,KR,NO,US);
C07D221/26 (EP,NO,US);
A61K31/485 (KR,NO);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/12 (EP);
A61P11/00 (EP);
A61P11/14 (EP);
A61P17/04 (EP);
A61P21/02 (EP);
A61P25/02 (EP);
A61P25/04 (EP);
A61P25/08 (EP);
A61P25/30 (EP);
A61P25/36 (EP);
A61P29/00 (EP);
A61P3/04 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
C07D215/14 (EP,US);
C07D215/20 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2010/46] | Title | German: | 4-Hydroxybenzomorphane | [2010/46] | English: | 4-Hydroxybenzomorphans | [2010/46] | French: | 4-Hydroxybenzomorphanes | [2010/46] | Examination procedure | 13.08.2010 | Examination requested [2010/46] | 16.05.2011 | Amendment by applicant (claims and/or description) | 07.07.2011 | Despatch of a communication from the examining division (Time limit: M04) | 02.11.2011 | Reply to a communication from the examining division | 12.12.2011 | Communication of intention to grant the patent | 15.03.2012 | Fee for grant paid | 15.03.2012 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP05851351.6 / EP1817291 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050851351) is 20.09.2007 | Opposition(s) | 12.02.2013 | No opposition filed within time limit [2013/16] | Fees paid | Renewal fee | 13.08.2010 | Renewal fee patent year 03 | 13.08.2010 | Renewal fee patent year 04 | 13.08.2010 | Renewal fee patent year 05 | 13.08.2010 | Renewal fee patent year 06 | 25.01.2012 | Renewal fee patent year 07 | Penalty fee | Additional fee for renewal fee | 30.11.2011 | 07 M06 Fee paid on 25.01.2012 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US2003187009 (WENTLAND MARK P [US]) [Y] 1-9 * page 12, paragraphs 27,28; claim - *; | [A]EP1359146 (RENSSELAER POLYTECH INST [US]) [A] 1-9* the whole document *; | [Y] - WENTLAND M P ET AL, "3-Carboxamido analogues of morphine and naltrexone synthesis and opioid receptor binding properties", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (2001), vol. 11, ISSN 0960-894X, pages 1717 - 1721, XP002196643 [Y] 1-9 * figure 1; examples 2,5,9 * DOI: http://dx.doi.org/10.1016/S0960-894X(01)00278-5 | [Y] - WENTLAND M P ET AL, "8-Carboxamidocyclazocine analogues - redefining the structure-activity relationships of 2,6-methano-3-benzazocines", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (20010312), vol. 11, no. 5, ISSN 0960-894X, pages 623 - 626, XP004230076 [Y] 1-9 * examples 15-17 * DOI: http://dx.doi.org/10.1016/S0960-894X(01)00014-2 | by applicant | WO0236573 | WO2004007449 | - WENTLAND ET AL., BIOORG.MED.CHEM.LETT., (2001), vol. 11, pages 623 - 626 | - BIOORG.MED.CHEM.LETT., (2001), vol. 11, pages 1717 - 1721 | - "Analgesics", ALDRICH, J.V., Burger's Medicinal Chemistry and Drug Discovery, JOHN WILEY & SONS, (1996), pages 321 - 44 | - WENTLAND ET AL., BIOORG. MED.CHEM. LETT., (2000), vol. 9, pages 183 - 187 | - JIANG ET AL., IL PHARMACOL. EXP. THER., (1993), vol. 264, pages 1021 - 1027 | - NEUMEYER ET AL., J. MED. CHEM., (2003), vol. 46, page 5162 | - WENTLAND ET AL., BIOORG. MED. CHEM. LETT., (2000), vol. 9, pages 183 - 187 | - WENTLAND ET AL., BIOORG. MED. CHEM. LETT, (2001), vol. 11, pages 623 - 626 | - BIOORG. MED. CHEM. LETT., (2001), vol. 11, pages 1717 - 1721 | - NAN ET AL., J. HETEROCYCLIC CHEM., (1997), vol. 34, pages 1195 - 1203 | - COOP ET AL., J. MED. CHEM., (1999), vol. 42, pages 1673 - 1679 | - COOP ET AL., J. MED. CHEM, (1999), vol. 42, pages 1673 - 1679 | - HETEROCYCLES, (1999), vol. 50, pages 39 - 42 | - WENTLAND ET AL., J. MED. CHEM, (2000), vol. 3, pages 3558 - 3565 | - KUBOTA ET AL., TETRAHEDRON LETTERS, (1998), vol. 39, no. 19, pages 2907 - 2910 |